TELA Bio Executive Acquires Equity Amid Operational Restructuring and Earnings Miss
Executive equity acquisition signals internal positioning amid recent operational adjustments and earnings misses. Second-quarter financial results diverged from consensus forecasts, prompting the strategic withdrawal of full-year revenue guidance. Margin expansion and unit volume growth in core segments contrast sharply with significant declines i…